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INTRODUCTION
IgA nephropathy (IgAN) is one of the most common primary 
glomerulonephritis worldwide. It slowly progresses to end stage 
renal disease (ESRD) within 20 years of onset in about one 
third of patients. Proteinuria, hypertension, and elevated se-
rum creatinine at presentation are the best known clinical fac-
tors related to disease progression.1 However, clinical courses 
vary greatly from patient to patient; metabolic, environmen-
tal, and uncertain genetic factors may have some role in this.2,3
Smoking is a well-known risk factor of cardiovascular dis-
ease, as well as renal dysfunction.4-7 In IgAN patients, cigarette 
smoking was reported to elevate serum creatinine levels and to 
be associated with renal disease progression.8,9 However, re-
search has yet to clarify whether cigarette smoking exerts its 
effects by triggering hemodynamic derangement or by aggra-
vation of renal structural changes. Circumstantial evidence and 
experimental data support the involvement of histologic dam-
age. Arterio- and arteriolosclerosis was reported to be a main 
histologic feature related to smoking.10 In addition, the glo-
merular mesangium, which is activated by aberrantly glyco-
sylated IgA111,12 may receive additional oxidative stress elicited 
by cigarette smoke in IgAN patients.13 In animal experiments, 
administration of nicotine, a major component of cigarette sm-
oke, caused mesangial proliferation and matrix increase.14 
Under the assumption of renal histologic progression by smok-
ing, a retrospective assessment of renal histology was per-
formed according to smoking history and dose. We further 
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performed glomerular immunohistology and arterial mor-
phometry to reveal the major sites of histologic injury upon 
smoking. Additionally, the influence of smoking on risk fac-
tors predictive of renal functional decline was explored.
MATERIALS AND METHODS
Subjects
A total of 397 IgAN cases diagnosed at the Department of Pa-
thology between January 2005 and December 2012 were re-
trieved from the clinical data repository of Yonsei University 
Severance Hospital. The inclusion criteria were as follows: age 
over 18 years at time of diagnosis; documentation of smoking 
history in electronic medical charts; and histologic confirma-
tion of IgAN by predominant mesangial IgA deposition on 
immunofluorescent microscopy and at least six glomeruli on 
light microscopy. We excluded cases with diabetes mellitus, 
hepatitis B or C viral carriers, renal transplantation patients or 
other renal disease patients, except for those with IgAN and 
hypertension. Smokers were further divided into three sub-
groups according to smoking amounts: <5 pack-years (PY), 
5–15 PY, and >15 PY.8 Renal functional decline after biopsy 
was assessed in cases in which urinary protein excretion and 
serum creatinine were measured more than two times at a 
6-month interval and follow-up times exceeded one year. The 
design and methods of the study were approved by the Insti-
tutional Review of Board of our institution. 
Histologic assessment and morphometry
Renal biopsy samples were processed for light microscopy, im-
munofluorescence, and electron microscopy. For light micros-
copy, formalin fixed, paraffin embedded sections were cut to 3 
um and stained with hematoxylin-eosin, periodic acid-Schiff 
(PAS), aldehyde fuchsin orange G, and periodic acid–silver 
methenamine methods. IgAN was diagnosed as the presence 
of predominant mesangial IgA deposition on immunofluores-
cence. The overall histologic severity was measured by the Haas 
subclass.15 The percentages of global and segmental glomeru-
losclerosis were calculated in each case. The degrees of tubu-
lar atrophy and interstitial fibrosis were graded from 0 to 3 (0, 
negative; 1, less than 25% of cortex affected; 2, 25–50% of cor-
tex affected; and 3, >50% of cortex affected) and were grouped 
into none to mild (0–1) and moderate to severe (2–3) subgroups 
for statistical analysis of follow-up data. All arterioles in PAS-
stained slides were evaluated for the presence of arteriolar hy-
alinosis. In arteries, the presence of arterial intimal thickening 
and its quantity were assessed using the image J program. Ev-
ery available artery in PAS-stained slides was captured under 
×200 magnification. The whole thickness of thickened and nor-
mal areas was measured in each artery and the ratio was cal-
culated. Histologic and morphometric evaluation was made 
without access to clinical information.
Immunohistochemistry
Thirty-nine cases each among smokers and non-smokers were 
selected by 1:1 matching for age, gender, hypertension, and 
IgAN subclass, applying propensity score matching method 
using SAS software, version 9.2 (SAS Institute Inc., Cary, NC, 
USA). Deparaffinized, 3-um thick renal sections were incubat-
ed with primary antibody against alpha-smooth muscle actin 
(α-SMA) (1A4, 1:1000, Dako, Glostrup, Denmark) and CD68 
(PG-M1, 1:500, Dako), and visualized using a DAB Map kit on 
Discovery XT (Ventana Medical Systems, Tucson, AZ, USA). 
Sections omitting primary antibody were used as negative con-
trols. Glomerular α-SMA expression was evaluated only in non-
sclerotic glomeruli demonstrating vascular hilum or a urinary 
pole. With image J, α-SMA stained areas were measured and 
the percentage thereof was calculated by dividing the sum of 
α-SMA area by the average glomerular area. Intraglomerular 
CD68+ macrophages were counted in nonsclerotic glomeruli 
and expressed as the average number per glomerulus.
Clinical parameters and renal outcome
Age, gender, hypertension, smoking and its amount, duration 
of follow-up, serum creatinine, serum IgA levels, and protein-
uria at the time of diagnosis and last follow-up were retrieved 
from electronic medical charts. Urinary protein and creatinine 
concentrations were measured from a random spot urine sam-
ple, and a urinary protein/creatinine ratio (UPCR) (g/g) was 
calculated as an index of proteinuria. Time-average (TA) pro-
teinuria was determined by TA-UPCR, averaging UPCRs ob-
tained in 6-month intervals after biopsy.16 Estimated glomeru-
lar filtration rate (eGFR) was calculated using the Modification 
of Diet in Renal Disease formula. Renal outcome was measured 




Results were expressed as mean±standard deviation. Data 
were analyzed with SPSS software for Windows (version 18.0; 
SPSS Inc., Chicago, IL, USA). Mann-Whitney U test was used 
to compare continuous variables, and Pearson’s chi-square test 
and Fisher’s exact test were used to compare categorical vari-
ables. Wilcoxon signed rank test was used for comparison of 
matched patients. Kruskal-Wallis test was used to compare dif-
ferences among the three smoker subgroups divided accord-
ing to smoking dose. A repeated measure ANOVA was used to 
assess changes in eGFR, serum creatinine, and UPCR. A Cox 
proportional hazards model was used to assess risk factors for 
serum creatinine doubling in follow-up cases. p<0.05 was 
considered significant. 
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RESULTS
Patient demographics according to smoking status 
and dose
In a cohort of 397 IgAN cases, 52 patients were current smok-
ers and 345 patients were non/ex-smokers. The current smok-
ers were predominantly male. Mean age was similar in both 
groups, but significantly increased among smokers as smok-
ing dose increased. Hypertension was more frequent and se-
rum creatinine level was significantly higher in current smok-
ers than in non/ex-smokers at the time of diagnosis; both 
increased markedly with higher smoking doses. UPCR and 
eGFR were not significantly different between smokers and 
non/ex-smokers, but significantly increased in heavy smokers 
in comparison to light smokers. Serum IgA quantitation was 
available in 305 patients at the time of biopsy. Mean serum 
IgA levels were not statistically different between smokers and 
non/ex-smokers. Heavy smokers tended to have higher IgA lev-
els than those of light smokers, although the levels were not 
statistically significant (Table 1 and 2).
Renal histology according to smoking status and dose
When renal histology was compared between smokers and 
non/ex-smokers, neither Haas histologic grades nor histologi-
cal parameters were significantly different (Table 3). The prev-
alence of arterial intimal thickening or the ratio of vascular wall 
thickness was not different according to smoking status or dose. 
Meanwhile, the percentages of global glomerulosclerosis and 
arteriolar hyalinosis were significantly increased as smoking 
dose increased in current smokers (Table 4). 
Glomerular immunohistology in a 1:1 matched cohort 
of current and non/ex-smokers
Glomerular injury by myofibroblastic activation and/or inflam-
matory cells was assessed by quantitation of α-SMA+ mesan-
gial areas and intraglomerular CD68+ cells after matching age, 
gender, and histologic severity in current and non/ex-smokers. 
α-SMA+ glomerular mesangial areas were similar between cur-
rent and non/ex-smokers; however, the number of CD68+ cells 








No. of cases 52 345
Age (yrs) 38.94±12.95 38.88±12.50 0.995
Gender (male) 46 (88.5%) 144 (41.7%) <0.001
Hypertension 18 (34.6%) 83 (24.1%) 0.124
eGFR (mL/min/1.73 m2) 72.98±24.29 77.15±24.74 0.185
Serum creatinine (mg/dL) 1.26±0.67 1.07±0.61 <0.001
Spot urine protein/creatinine 1.12±1.33 1.25±1.50 0.441






eGFR, estimated glomerular filtration rate.
Table 2. Clinical Parameters According to Smoking Dose at Time of Diagnosis
Smoking dose (PY) <5 5–15 >15 p value
No. of cases 15 19 18
Age 26±7.40 38.47±7.41 50.22±10.81 <0.001
Gender (male) 13 (28.3%) 18 (39.1%) 15 (32.6%) 0.563
Hypertension 1 (6.7%) 8 (42.1%) 9 (50.0%) 0.024
eGFR (mL/min/1.73 m2) 93.52±22.41 65.84±21.21 63.41±18.79 0.002
Serum creatinine (mg/dL) 0.98±0.21 1.49±1.01 1.24±0.29 0.017
Spot urine protein/creatinine 0.42±0.38 1.14±1.17 1.60±1.68 0.011
Serum IgA levels (mg/dL) 266.46±80.67 (n=13) 327.13±119.15 (n=15) 383.44±156.08 (n=9) 0.129
eGFR, estimated glomerular filtration rate; PY, pack-years.







No. of cases 52 345
IgA nephropathy, Haas grade 0.105
1 6 (11.5%) 63 (18.3%)
2 6 (11.5%) 72 (20.9%)
3 24 (46.2%) 113 (32.8%)
4 9 (17.3%) 71 (20.6%)
5 7 (13.5%) 26 (7.5%)
Global sclerosis (%) 17.29±19.11 13.37±17.21 0.119
Segmental sclerosis (%) 7.46±10.23 7.78±12.00 0.835
Tubular atrophy 0.689
Absent 14 (26.9%) 89 (25.8%)
Mild 31 (59.6%) 218 (63.2%)
Moderate 6 (11.5%) 35 (10.1%)
Severe 1 (1.9%) 3 (0.9%)
Interstitial fibrosis 0.391
Absent 15 (28.8%) 121 (35.1%)
Mild 31 (59.6%) 200 (58.0%)
Moderate 5 (9.6%) 21 (6.1%)
Severe 1 (1.9%) 3 (0.9%)
Arteriolar hyalinosis 11 (21.2%) 54 (15.7%) 0.318
Arterial fibrointimal thickening 6 (11.5%) 37 (19.4%) 0.171
Ratio of arterial thickened wall 
  to normal wall
1.48±0.28 1.57±0.38 0.508
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was significantly less in smokers (Table 5). CD68+ cell infiltra-
tion did not show correlation with any clinical or histologic 
variables or α-SMA expression by univariate analysis. In mul-
tivariate analysis, however, global glomerulosclerosis was 
negatively correlated and segmental glomerulosclerosis was 
positively correlated with CD68+ cell infiltration (Table 6). 
Table 4. Renal Histology According to Smoking Dose
Smoking dose (PY) <5 5–15 >15 p value
No. of cases 15 19 18
IgA nephropathy, Haas grade 0.095
1 3 (20.0%) 2 (10.5%) 1 (5.6%)
2 1 (6.7%) 3 (15.8%) 2 (11.1%)
3 11 (73.3%) 6 (31.6%) 7 (38.9%)
4 0 (0.0%) 5 (26.3%) 4 (22.2%)
5 0 (0.0%) 3 (15.8%) 4 (22.2%)
Global sclerosis (%) 6.86±11.28 20.66±18.79 22.44±21.92 0.043
Segmental sclerosis (%) 7.02±9.96 6.88±10.20 8.43±10.99 0.965
Tubular atrophy 0.313
Absent 6 (40.0%) 3 (15.8%) 5 (27.8%)
Mild 9 (60.0%) 12 (63.2%) 10 (55.6%)
Moderate 0 (0.0%) 4 (21.1%) 2 (11.1%)
Severe 0 (0.0%) 0 (0.0%) 1 (5.6%)
Interstitial fibrosis 0.277
Absent 7 (46.7%) 3 (15.8%) 5 (27.8%)
Mild 8 (53.3%) 13 (68.4%) 10 (55.6%)
Moderate 0 (0.0%) 2 (15.8%) 2 (11.1%)
Severe 0 (0.0%) 0 (0.0%) 1 (5.6%)
Arteriolar hyalinosis 0 (0.0%) 5 (26.3%) 6 (33.3%) 0.034
Arterial fibrointimal thickening 0 (0.0%) 2 (10.5%) 4 (22.2%) 0.187
PY, pack-years.
Table 5. Clinical Features and Renal Histology in a 1:1 Matched Cohort of Current and Non- or Ex-Smokers in IgAN Patients (Total n=78)
Smoking status Current smokers Non/ex-smokers p value
No. of cases 39 39
eGFR at time of diagnosis 73.71±23.51 71.22±24.73 0.388
Serum creatinine at time of diagnosis 1.21±0.58 1.28±0.60 0.240
Spot UPCR at time of diagnosis 0.84±0.79 0.92±1.15 0.402
Global sclerosis (%) 15.09±17.78 15.57±18.69 0.971
Segmental sclerosis (%) 7.56±9.92 7.46±13.16 0.700
No. of glomerular CD68+ cells 1.78±1.18 2.53±1.56 0.039
Glomerular mesangial α-SMA+ area (%) 0.22±0.22 0.27±0.20 0.478
Tubular atrophy 0.621
Absent 7 (17.9%) 11 (28.2%)
Mild 26 (66.7%) 20 (51.3%)
Moderate 5 (12.8%) 7 (17.9%)
Severe 1 (2.6%) 1 (2.6%)
Interstitial fibrosis 0.817
Absent 10 (25.6%) 14 (35.9%)
Mild 25 (64.1%) 21 (53.8%)
Moderate 3 (7.7%) 3 (7.7%)
Severe 1 (2.6%) 1 (2.6%)
Arteriolar hyalinosis 8 (20.5%) 11 (28.2%) 0.549
Arterial fibrointimal thickening 2 (5.1%) 8 (20.5%) 0.070
Ratio of arterial thickened wall to normal wall 1.57±0.38 1.48±0.28 0.508
UPCR, urine protein/creatinin ratio; eGFR, estimated glomerular filtration rate; IgAN, IgA nephropathy; α-SMA, alpha-smooth muscle actin.
213http://dx.doi.org/10.3349/ymj.2016.57.1.209
Yoon Jin Cha, et al.
Clinical course according to smoking status and dose
Data for use in evaluating renal functional decline was avail-
able in 283 IgAN patients. After a mean follow-up of 3.8 years, 
serum creatinine levels were significantly higher and eGFR 
tended to be lower in current smokers than in non/ex-smok-
ers. However, the proportion of patients with serum creatinine 
level elevated 50% or more from baseline (Δ serum creatinine 
≥50%) at last follow-up was not different between smokers 
and non/ex-smokers. Proteinuria measured as UPCR was sig-
nificantly increased in current smokers and decreased in 
non/ex-smokers after follow-up (Table 7). Serum IgA levels 
were measured more than twice in 71 patients during follow-
up: IgA levels tended to decrease in both groups. However, the 
rate of decrease was not significantly different between cur-
rent smokers (-0.01±0.16, n=7) and non/ex-smokers (-0.33± 
0.16, n=64) (p=0.732).
When risk factors of serum creatinine doubling were as-
sessed in all IgAN patients, hypertension, serum creatinine lev-
el, eGFR, global glomerulosclerosis, tubular atrophy, and ar-
teriolar hyalinosis were significant in univariate Cox propor-
tional hazards analysis. However, when the cases were divided 
into smokers and non/ex-smokers, the risk factors included 
serum creatinine level, eGFR, and global glomerulosclerosis 
in both groups by univariate analysis and eGFR in non/ex-
smokers by multivariate analysis (Table 8). 
DISCUSSION
In addition to intrinsic immune complex-mediated renal inju-
ry, environmental stimuli and personal habits may further trig-
ger disease activity and progression in patients with IgAN. In 
the present study, we explored smoking effects on renal func-
tion and histology in IgAN patients. Smoking showed deleteri-
ous effects on renal function. Serum creatinine levels were 
higher in smokers than in non/ex-smokers. With increasing 
smoking dose, the prevalence of hypertension, serum creati-
nine level, and urinary protein excretion increased significant-
ly. Current smokers were predominantly male and of older age 
as smoking dose increased. Interestingly, male gender and old-
er age were reported to be risk factors for ESRD in some stud-
ies of IgAN,17,18 which raises suspicions of smoking being an 
offender. Moreover, estrogen deficiency may increase nico-
tine-induced renal injury.19
Renal histology in terms of Haas grades or individual histo-
logic parameters was not different between current smokers 
and non/ex-smokers. Haas grades tended to be higher in 
heavy smokers than in light smokers, although without statis-
tical significance. We further tested whether membranoprolif-
erative features are associated with smoking. Five cases (one 
current smoker and four non/ex-smokers) showed a double 
contour feature of glomerular capillary walls, and four of them 
had subendothelial electron dense deposits. However, statisti-
cal analysis was not possible due to the small number of pa-
Table 6. Regression Analysis for Glomerular CD68 Infiltration in a 1:1 
Matched Cohort
Parameter β coefficient p value
Univariate analysis
Age 0.003±0.014 0.803
Smoking dose 0.006±0.021 0.767
Hypertension -0.316±0.364 0.388
eGFR at time of diagnosis 0.006±0.007 0.409
Serum creatinine at time of diagnosis -0.184±0.283 0.518
Spot UPCR at time of diagnosis -0.041±0.157 0.797
IgA nephropathy, Haas grade -0.095±0.151 0.530
Global sclerosis (%) -0.004±0.009 0.648
Segmental sclerosis (%) 0.010±0.014 0.504
Mesangial α-SMA positive area (%) -0.357±0.981 0.718
Tubular atrophy 0.206±0.235 0.382
Interstitial fibrosis -0.111±0.248 0.655
Arteriolar hyalinosis 0.195±0.389 0.618
Arterial fibrointimal thickening 0.528±0.507 0.301
Multivariate analysis (%)
Global sclerosis -0.030±0.011 0.008
Segmental sclerosis 0.067±0.019 0.001
UPCR, urine protein/creatinin ratio; eGFR, estimated glomerular filtration 
rate; α-SMA, alpha-smooth muscle actin.




At time of diagnosis At last follow-up At time of diagnosis At last follow-up
No. of cases 40 243
Age (yrs) 39.13±12.24 39.45±12.60 0.890
Gender (male) 34 (85.0%) 99 (40.7%) <0.001
Hypertension 15 (37.5%) 65 (26.7%) 0.162
eGFR (mL/min/1.73 m2) 73.33±23.33 74.15±32.39 74.43±23.30 79.88±29.90 0.071
Serum creatinine (mg/dL) 1.21±0.57 1.69±2.53 1.11±0.69 1.15±1.15 0.015
Δ serum creatinine ≥50% at last follow-up (%) 5 (10.0%) 20 (6.0%) 0.086
Spot UPCR 0.96±0.97 1.01±1.18 1.32±1.59 0.76±1.04 0.008
Time-average spot UPCR 0.86±0.78 0.89±1.21 0.073
UPCR, urine protein/creatinin ratio; eGFR, estimated glomerular filtration rate.
http://dx.doi.org/10.3349/ymj.2016.57.1.209214
Smoking and IgA Nephropathy
tients having these features. In contrast, the percentage of glob-
al glomerulosclerosis and the prevalence of arteriolar hyalinosis 
increased with increased smoking doses. While it would be 
difficult for us to judge which of the two lesions comes first, the 
presence of arteriolar hyalinosis may hamper glomerular per-
fusion and increase the speed of glomerulosclerosis. In con-
trast to microvascular changes, the degrees of tubulointersti-
tial fibrosis and arteriosclerosis were not different according 
to smoking status or doses. Tubulointerstitial fibrosis was 
generally mild: 11.5% of smokers and 7% of non/ex-smokers 
showed moderate to severe interstitial fibrosis. In heavy smok-
ers, its prevalence increased to 16.7%. As we used a crude four-
tiered scale in the assessment of interstitial fibrosis, quantita-
tive morphometric assessment might have revealed subtle 
differences. Since neither the presence of arteriosclerosis nor 
arterial wall thickness differed between smokers and non/ex-
smokers, we thought that glomeruli and arterioles are the 
main targets of smoking-related injury in IgAN patients. These 
findings are different from those reported by Lhotta, et al.,10 
who claimed small interlobular arteries to be the main targets 
of smoking-related injury. This discrepancy may be attributed 
to differences in smoker grouping and the study cohorts be-
tween the two studies. We divided cases into current smokers 
and non/ex-smokers at the time of biopsy, instead of never-
smokers and ever-smokers. More importantly, we comprised 
only IgAN cases of which histologic severity of each compart-
ment was assessed using the same evaluation method, where-
as their study included various glomerular diseases with di-
verse etiology, clinical presentation, and histology,10 and thus, 
only vascular assessment was feasible. 
As ancillary markers of glomerular injury, glomerular CD68+ 
macrophage infiltration and mesangial α-SMA expression 
were compared between smokers and non/ex-smokers. Glo-
merular α-SMA expression is regarded as myofibroblastic trans-
formation of mesangial cells and a marker of mesangial cell 
activation.20 It has been reported to be related to disease activ-
ity21 and renal functional decline in IgAN patients.22 Nicotine 
treatment has been found to induce mesangial cell prolifera-
tion and fibronectin production in human mesangial cell cul-
ture.14 However, in the present study, the extent of mesangial 
α-SMA+ areas did not differ according to smoking status, rath-
er by histologic severity based on Haas grades. As cases were 
previously matched for Haas grades, we thought that similar 
histologic injuries could not be further distinguished by α-SMA 
expression. On the contrary, the number of CD68+ cells was 
significantly less in smokers than in non/ex-smokers. CD68+ 
cells showed no significant correlation with any clinical or his-
tologic factors or α-SMA expression in univariate analysis, al-
though global glomerulosclerosis was negatively correlated and 
segmental glomerulosclerosis was positively correlated with 
CD68+ cell infiltration in multivariate analysis. Glomerular 
macrophage infiltration was previously reported to be corre-
lated with mesangial and endocapillary proliferation in chil-
dren23 and with glomerular matrix expansion and segmental/
global glomerulosclerosis in adults with IgAN.24 In a proteinuric 
rat model, long-term oral nicotine-treatment reduced glo-
merular macrophage infiltration, glomerulosclerosis, and in-
terstitial α-SMA expression.25 Our results led us to speculate 
Table 8. Risk Factors of Serum Creatinine Doubling by a Cox Proportional Hazards Model
Variables
Univariate Multivariate
Hazard ratio (CI) p value Hazard ratio (CI) p value
Non/ex-smokers
Age 1.05 (0.98–1.13) 0.144
Hypertension NA
Serum creatinine at time of diagnosis 1.86 (1.23–2.83) 0.003  
eGFR at time of diagnosis 0.93 (0.89–0.97) 0.002 0.93 (0.89–0.97) 0.002
Spot UPCR at time of diagnosis NA
Global sclerosis (%) 1.04 (1.01–1.08) 0.013
Segmental sclerosis (%) 1.04 (0.99–1.09) 0.149
Tubular atrophy 4.65 (0.91–23.87) 0.066
Interstitial fibrosis 1.90 (0.22–16.36) 0.558
Arteriolar hyalinosis 3.05 (0.54–17.35) 0.208
Arterial thickening 3.32 (0.60–18.24) 0.168
Smokers
Smoking dose 1.04 (0.89–1.21) 0.626
Serum creatinine at time of diagnosis 2.94 (1.18–7.34) 0.021
eGFR at time of diagnosis 0.92 (0.85–0.99) 0.033
Global sclerosis (%) 1.07 (1.01–1.13) 0.022
Segmental sclerosis (%) 1.07 (0.94–1.21) 0.333
CI, confidence interval; NA, not available due to small number of event; UPCR, urine protein/creatinin ratio; eGFR, estimated glomerular filtration rate.
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that macrophages are associated with an active state of glomer-
ular matrix laydown and sclerosis. As macrophages play dif-
ferent roles in inflammation and tissue repair depending on 
subsets of patients,24,26 further clarification of whether macro-
phage phenotypes differ according to smoking status and stag-
es of IgAN is needed. 
In the present study, the risk factors of serum creatinine dou-
bling were not different according to smoking status. Renal 
function at time of diagnosis and global glomerulosclerosis 
were significant in both smokers and non/ex-smokers in uni-
variate analysis. The speed of renal functional decline was sim-
ilar in both groups, as shown by the proportion of patients with 
Δ serum creatinine ≥50% at last follow-up. Proteinuria per se 
was not significant either. However, increased proteinuria af-
ter follow-up may suggest disease progression in smokers.2,3 
Taken together, the lack of significant harmful effects on renal 
disease progression by smoking seems to implicate a domi-
nant role of functional derangement over irreversible histo-
logical changes by smoking. Nevertheless, the short follow-up 
period, the small proportion of smokers, and the only 3.5% of 
cases with creatinine doubling may prevent us from unveiling 
definite histologic clues.
The study has several limitations. First, it was not certain 
whether smoking status at diagnosis would be continued dur-
ing follow-up in our patients. However, we expected that the 
number of patients who changed smoking habits might be 
negligible over the 3.8 year follow-up period. Among clinical 
factors, age was significantly increased with increased smok-
ing dose. Although we could not completely eliminate age ef-
fects on renal histology, significant changes were limited to 
glomeruli and arterioles in old heavy smokers. When we eval-
uated the influence of aging on histology in non/ex-smokers, 
significant progression occurred in all histologic compartments 
by univariate analysis and in interstitium, arterioles, and ar-
teries by multivariate analysis by linear regression analysis (data 
not shown). Another factor omitted in the evaluation was ef-
fects of angiotensin converting enzyme inhibitors (ACEI) on 
IgAN and smoking-induced renal dysfunction.27 Although we 
did not check the proportion of patients under ACEI treatment, 
TA proteinuria was not different between the two groups. As 
we mentioned previously, the relatively short follow-up might 
have masked more definite evidence, although the mixed ef-
fects of glomerulonephritis, smoking, and others might be an 
obstacle for interpretation in advanced stage disease. 
In conclusion, smoking causes dose dependent harmful ef-
fects on the kidneys in IgAN patients. In addition to renal func-
tional decline and elevated blood pressure, glomerulosclero-
sis and arteriolar hyalinosis may contribute to renal disease 
progression in these patients.
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